102 related articles for article (PubMed ID: 9428286)
1. Association of valvular heart disease with Chinese-herb nephropathy.
Vanherweghem JL
Lancet; 1997 Dec 20-27; 350(9094):1858. PubMed ID: 9428286
[No Abstract] [Full Text] [Related]
2. Valvular heart disease and Chinese-herb nephropathy.
Van Ypersele de Strihou C
Lancet; 1998 Mar; 351(9107):991; author reply 991-2. PubMed ID: 9734973
[No Abstract] [Full Text] [Related]
3. Valvular heart disease and Chinese-herb nephropathy.
Ono T; Eri M; Honda G; Kuwahara T
Lancet; 1998 Mar; 351(9107):991-2. PubMed ID: 9734974
[No Abstract] [Full Text] [Related]
4. High prevalence of fenfluramine-related aortic regurgitation in women with end-stage renal disease secondary to Chinese herb nephropathy.
Unger P; Nortier J; Muniz Martinez MC; Plein D; Vandenbossche JL; Vereerstraeten P; Vanherweghem JL
Nephrol Dial Transplant; 2003 May; 18(5):906-10. PubMed ID: 12686663
[TBL] [Abstract][Full Text] [Related]
5. Fen-phen and risk of valvular disease.
SoRelle R
Circulation; 1997 Sep; 96(6):1705-6. PubMed ID: 9323046
[No Abstract] [Full Text] [Related]
6. Anorectic drugs and valvular heart disease.
Krynicki PF
Cleve Clin J Med; 1998 May; 65(5):277; author reply 277-8. PubMed ID: 9599914
[No Abstract] [Full Text] [Related]
7. Valvular heart disease associated with fenfluramine-phentermine.
Kurz X; Van Ermen A
N Engl J Med; 1997 Dec; 337(24):1772-3; author reply 1775. PubMed ID: 9411247
[No Abstract] [Full Text] [Related]
8. Appetite-suppressant drugs and valvular heart disease.
Williamson DF; Yanovski SZ
N Engl J Med; 1999 Feb; 340(6):476; author reply 478-80. PubMed ID: 9988618
[No Abstract] [Full Text] [Related]
9. Appetite suppressants and valvular heart disease.
Devereux RB
N Engl J Med; 1998 Sep; 339(11):765-6. PubMed ID: 9731094
[No Abstract] [Full Text] [Related]
10. Appetite-suppressant drugs and valvular heart disease.
Shapiro S
N Engl J Med; 1999 Feb; 340(6):477-8; author reply 478-80. PubMed ID: 9988622
[No Abstract] [Full Text] [Related]
11. Valvular heart disease associated with fenfluramine-phentermine.
Redmon B; Raatz S; Bantle JP
N Engl J Med; 1997 Dec; 337(24):1773-4; author reply 1775. PubMed ID: 9411249
[No Abstract] [Full Text] [Related]
12. Valvular heart disease associated with fenfluramine-phentermine.
Wolff FW
N Engl J Med; 1997 Dec; 337(24):1774; author reply 1775-6. PubMed ID: 9411250
[No Abstract] [Full Text] [Related]
13. Further cases of valvular heart disease associated with fenfluramine-phentermine.
Graham DJ; Green L
N Engl J Med; 1997 Aug; 337(9):635. PubMed ID: 9280830
[No Abstract] [Full Text] [Related]
14. Anorectic therapy and valvular heart disease: a reappraisal.
Silvestry FE; St John Sutton M
Eur Heart J; 1999 Jul; 20(13):917-20. PubMed ID: 10361039
[No Abstract] [Full Text] [Related]
15. Chinese herb nephropathy is not a (dex)fenfluramine nephropathy but a serotonin nephropathy.
Malak J
J Altern Complement Med; 1998; 4(2):131-2. PubMed ID: 9628201
[No Abstract] [Full Text] [Related]
16. Anorectic drugs and valvular heart disease: a biological and clinical perspective.
Wong J; Reddy SS; Klein AL
Cleve Clin J Med; 1998 Jan; 65(1):35-41. PubMed ID: 9465454
[TBL] [Abstract][Full Text] [Related]
17. Risks of heart-valve abnormalities with appetite suppressants.
Baird IM
Lancet; 1998 Oct; 352(9138):1403-4. PubMed ID: 9807983
[No Abstract] [Full Text] [Related]
18. Benfluorex: the last chapter of drug-induced valvular heart disease?
Droogmans S; Cosyns B; Van Camp G
Eur J Echocardiogr; 2011 Apr; 12(4):263-4. PubMed ID: 21193483
[No Abstract] [Full Text] [Related]
19. Valvular heart disease associated with benfluorex.
Gueffet JP; Piriou N; Trochu JN
Arch Cardiovasc Dis; 2010 May; 103(5):342-3. PubMed ID: 20619246
[No Abstract] [Full Text] [Related]
20. More on heart disease and diet pills.
Harv Heart Lett; 2000 Jul; 10(11):5-6. PubMed ID: 10877859
[No Abstract] [Full Text] [Related]
[Next] [New Search]
